| | | VCCC in the News |  |  | Oncology News Australia • Dec 11, 2020 16:10 |  | | Find out why coffee is so good for you and hear the team sing Baby Shark in Episode 18 of The Oncology Journal Club! Eva ... funding for The Albury Wodonga Regional Cancer Centre which opened in September 2016. Dr Underhill is the VCCC Regional Oncology Lead and |
|
|
| | | Partners | | | Triple R - Melbourne Independent Radio - 102.7FM • Dec 10, 2020 13:56 | | | Dr. Sonia Fullerton is a palliative care doctor at the Peter MacCallum Cancer Centre with an interest in ‘advanced care planning’, which ... Dr. Sonia Fullerton is a palliative care doctor at the Peter MacCallum Cancer Centre with an interest in ‘advanced care planning’, which |
|
| | Premier of Victoria • Dec 8, 2020 23:2 | | | The Andrews Labor Government is expanding vital palliative care facilities at the Parkville Precinct. Minister for Health Martin Foley ... 12 new palliative care beds are now fully operational at the Peter MacCallum Cancer Centre – taking the total number of beds at The Royal |
|
|
| | | Reproductive Cancers | | | The New Daily • Dec 11, 2020 22:0 | | | The day before her 28th birthday, Jordan Turner was diagnosed with ovarian cancer. The first sign, possibly, was a case of shingles – a ... risk. The survey, by the Ovarian Cancer Research Foundation and the Melbourne School of Psychological Sciences found that: 68 per cent of |
|
| | 7NEWS.com.au • Dec 11, 2020 9:54 | | | The Federal Government is being called on to fund a test that would stop thousands of breast cancer sufferers from undergoing chemotherapy ... and is not currently publicly funded in Australia. The test could stop thousands of Australian women from undergoing chemo each year. Credit |
|
| | The Sector • Dec 10, 2020 11:37 | | | Returning to work can play an important role in recovery for breast cancer survivors – but workplace flexibility is key, according to new ... return-to-work practices that better respond to individual needs. “Australia’s relative five-year survival rate of 91 per cent and our |
|
| | Small Caps • Dec 9, 2020 22:55 | | | Global biotechnology company Immutep (ASX: IMM) has announced its Chinese partner EOC Pharma will commence a phase II clinical trial to ... latest news, events, and stock alerts. ASX CODE IMM Previous articleWill Australia use iron ore as a lever to fix trade with China? Next |
|
|
| | | Treatment Development | | | 9News • Dec 11, 2020 20:6 | | | Australian researchers are developing a new screening tool to identify bowel cancer in its early stages. The disease is the second most ... Australian researchers are developing a new screening tool to identify bowel cancer in its early stages. The disease is the second most |
|
| | The Market Herald • Dec 10, 2020 9:15 | | | Clinical-stage immuno-oncology company Imugene (IMU) has received a hefty tax rebate for its research and development (R&D) spending The ... million as part of the Australian government's R&D tax incentive program The scheme provides eligible Australian companies with an offset |
|
|
| | | Covid-19 & Cancer | | | Analysis and Policy Observatory • Dec 9, 2020 11:16 | | | Description Abstract: The coronavirus disease 2019 (COVID-19) pandemic has caused major disruptions to many aspects ... to many aspects of life in Australia and globally. This includes actual and potential future impacts on Australia’s three national screening |
|
|
|
|
|
|
